Non-Muscle Invasive Bladder Cancer (NMIBC) Clinical Trial
Official title:
Phase I/II Trial of Bacillus Calmette-Guérin (BCG) and Intravesical Gemcitabine for Patients With BCG-Relapsing High-Grade Non-Muscle Invasive Bladder Cancer
This study will test the safety of BCG and gemcitabine in people who have BCG-relapsing Non-Muscle Invasive Bladder Cancer (NMIBC). The researchers will test increasing doses of gemcitabine to find the highest dose that causes few or mild side effects when combined with BCG. The study will also look at whether this combination of drugs is effective in treating BCG-relapsing NMIBC.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03839472 -
Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors
|
N/A | |
| Completed |
NCT03672240 -
Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment
|
Phase 1/Phase 2 | |
| Terminated |
NCT03719300 -
Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC
|
Phase 2 | |
| Terminated |
NCT03167151 -
Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03148158 -
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
|
N/A | |
| Terminated |
NCT06069453 -
Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.
|
N/A | |
| Completed |
NCT02009332 -
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05176145 -
Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test
|
N/A |